The Board of Directors of ConceptoMed AS have the pleasure of announcing the successful completion of a private placement of equity in ConceptoMed AS. Following the share issue, the number of Shareholders in the company amounts to 35 (previously 34). Gross proceeds from the private placement amounts to NOK 9.5 Million (€1.05 Million).
On Monday 19th of January 2015, Runar Bjørklund, shareholder in ConceptoMed AS and former CFO of Nycomed, was appointed new Chairman of the Board. Runar Bjørklund keeps bringing extensive pharma- and financial market experience to the team.
– We are very pleased with the appointment of Runar Bjørklund as new Chairman of the Board, as well as with the participation in this private placement. The team is also very grateful for the extensive contribution which Sverre Christoffersen has made in his role as Chairman of the Board. Mr. Christoffersen will continue as Director on the Board of the company, says CEO Christian Mide.
ConceptoMed AS stands before an exciting international development of both Luer-Jack ™ and ConceptoShield ™.
The share issue values ConceptoMed AS at NOK 100.8 million (€11 Million).
